Travere Therapeutics (TVTX) is up 33.0%, or $10.13 to $40.83.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TVTX:
- Midday Fly By: Amazon to buy Globalstar, J&J posts ‘beat and raise’ report
- Travere Therapeutics upgraded to Overweight from Neutral at Piper Sandler
- Travere Therapeutics upgraded to Overweight at Piper after FSGS approval
- Ligand price target raised to $243 from $239 at H.C. Wainwright
- Travere Therapeutics rises 32.5%